Estrogen-only hormone therapy could lower risk of Alzheimer’s
In a retrospective study, people taking estrogen-only hormone therapy for menopause were less likely to see signs of dementia
A new study suggests that estrogen-only hormone therapy for menopause may lower the risk of Alzheimer's disease. In a retrospective analysis of 21,462 patient records, women who used estrogen-only therapy were less likely to develop signs of memory loss, cognitive decline, or dementia compared to those who did not. Furthermore, the brains of patients who took estrogen-only hormone therapy showed fewer neurobiological markers of Alzheimer's, such as beta-amyloid plaques and tau protein tangles.
However, the study does not prove that estrogen-only therapy prevents or treats dementia, as there could be other factors at play.
Written by urgent.news from Scientific American's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- A new target in the gut for reducing Alzheimer's risk medicalxpress.com
